Showing results (1-10 of 335) with videos related to
Sort By:
Pageof 34
Expert Review of Endocrinology & Metabolism|February 16, 2019
The potential of glucagon-like peptide 1 to reverse high-fat, high-sugar diet-related metabolic damageTimo D MüllerThe American Journal of Medicine|January 4, 2011
Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implicationsMichael A NauckThe American Journal of Medicine|May 26, 2009
Unraveling the science of incretin biologyMichael A NauckEuropean Journal of Internal Medicine|July 8, 2009
Unraveling the science of incretin biologyMichael A NauckDiabetes Care|May 7, 2013
A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risksMichael A NauckDrug Design, Development and Therapy|September 24, 2014
Update on developments with SGLT2 inhibitors in the management of type 2 diabetesMichael A NauckInternational Journal of Molecular Sciences|January 16, 2020
Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue "The Biology and Pharmacology of Glucagon"Timo D Müller, Kirk HabeggerPeptides|March 25, 2024
Regulation of energy metabolism through central GIPR signalingArkadiusz Liskiewicz, Timo D MüllerMed (New York, N.Y.)|December 9, 2023
SURMOUNTing body weight barriers in type 2 diabetesAaron Novikoff, Timo D MüllerPageof 34